BofA lowered the firm's price target on Parsons to $80 from $90 and keeps a Buy rating on the shares. The firm says investors remain concerned about the company's second half of 2026 weighted growth despite its "strong" Q1 report. The concerns are overdone and Parsons' outlook is achievable, supported by existing contracts, the analyst tells investors in a research note.
